Wells Fargo Upgrades Q32 Bio to Overweight, Announces $66 Price Target

Benzinga Newsdesk www.benzinga.com Positive 91.3%

Neg 0% Neu 0% Pos 91.3%

Wells Fargo analyst Derek Archila upgrades Q32 Bio (NASDAQ:QTTB) from Equal-Weight to Overweight and announces $66 price target.